Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Argus Health
Queensland Health
US Department of Justice
Accenture
Teva
Daiichi Sankyo
Chinese Patent Office
Dow
Chubb

Generated: January 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,633,008

« Back to Dashboard

Summary for Patent: 5,633,008
Title: Method of administering nicotine transdermally
Abstract:A method of administering nicotine transdermally in which a nicotine patch, capable of administering nicotine for at least 16 hours at rates that are efficacious in smoking cessation therapy, is applied in the morning upon waking and removed prior to sleep. This method is effective even though nicotine is not essential during sleep and many smokers experience morning craving.
Inventor(s): Osborne; James L. (Mountain View, CA), Nelson; Melinda K. (Sunnyvale, CA), Enscore; David J. (Saratoga, CA), Yum; Su I. (Los Altos, CA), Gale; Robert M. (Los Altos, CA), Causey; Donna D. (Camarillo, CA)
Assignee:
Application Number:08/105,262
Patent Claim Types:
see list of patent claims
Use; Device;

Drugs Protected by US Patent 5,633,008

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,633,008

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 161734 ➤ Subscribe
Australia 3852189 ➤ Subscribe
Australia 3913695 ➤ Subscribe
Australia 4491193 ➤ Subscribe
Australia 630614 ➤ Subscribe
Australia 666208 ➤ Subscribe
Australia 682813 ➤ Subscribe
Australia 684394 ➤ Subscribe
Australia 8585291 ➤ Subscribe
Canada 1338700 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Farmers Insurance
Fish and Richardson
Harvard Business School
Deloitte
Cipla
McKesson
Cerilliant
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot